Ito, Masami
Tajika, Aran
Toyomoto, Rie
Imai, Hissei
Sakata, Masatsugu
Honda, Yukiko
Kishimoto, Sanae
Fukuda, Memori
Horinouchi, Noboru
Sahker, Ethan
Furukawa, Toshi A.
Article History
Received: 22 February 2023
Accepted: 9 April 2024
First Online: 27 April 2024
Declarations
:
: Not applicable.
: Not applicable.
: AT has received lecture fees from Sumitomo Dainippon Pharma, Eisai, Janssen Pharmaceutical, Meiji-Seika Pharma, Mitsubishi Tanabe Pharma, Otsuka, and Takeda Pharmaceutical. HI received honoraria for lectures from Otsuka Pharmaceutical. MS reports personal fees from SONY outside the submitted work. MF is employees of Aillis, Inc., outside the submitted work. TAF reports grants and personal fees from Mitsubishi-Tanabe, personal fees from SONY, grants and personal fees from Shionogi, outside the submitted work; In addition, TAF has a patent 2020-548587 concerning smartphone CBT apps pending, and intellectual properties for Kokoro-app licensed to Mitsubishi-Tanabe. All the other authors declare that they have no competing interests.